{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:10:21Z","timestamp":1787508621432,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ajem.2023.04.020","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T11:59:05Z","timestamp":1682683145000},"page":"10-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["A systematic review of sufentanil for the management of adults with acute pain in the emergency department and pre-hospital setting"],"prefix":"10.1016","volume":"70","author":[{"given":"Caitlin","family":"Hutchings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishan","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren J.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayler","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Eagles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2023.04.020_bb0005","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ajem.2014.01.015","article-title":"Prevalence and treatment of pain in EDs in the United States, 2000 to 2010","volume":"32","author":"Chang","year":"2014","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2023.04.020_bb0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0304-3959(00)00361-4","article-title":"Pain as a reason to visit the doctor: a study in Finnish primary health care","volume":"89","author":"M\u00e4ntyselk\u00e4","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.ajem.2023.04.020_bb0015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.acpain.2008.05.013","article-title":"Management of pain in a surgical emergency unit\u2014underlying factors affecting its delivery","volume":"10","author":"Grenman","year":"2008","journal-title":"Acute Pain"},{"key":"10.1016\/j.ajem.2023.04.020_bb0020","unstructured":"Elsevier: Rosen's emergency medicine: Concepts and clinical practice, 9th Edition: Walls, Hockberger & Gausche-Hill. https:\/\/www.elsevier.ca\/ca\/product.jsp?isbn=9780323354790 (accessed 10 May 2021)."},{"key":"10.1016\/j.ajem.2023.04.020_bb0025","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/583132","article-title":"Management of Pain in the emergency department","volume":"2013","author":"Thomas","year":"2013","journal-title":"ISRN Emerg Med"},{"key":"10.1016\/j.ajem.2023.04.020_bb0030","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jpain.2006.12.005","article-title":"Pain in the emergency department: results of the pain and emergency medicine initiative (PEMI) multicenter study","volume":"8","author":"Todd","year":"2007","journal-title":"J Pain"},{"key":"10.1016\/j.ajem.2023.04.020_bb0035","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.ajem.2006.05.004","article-title":"Analgesia delivery in the ED","volume":"24","author":"Grant","year":"2006","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2023.04.020_bb0040","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1136\/emermed-2013-203079","article-title":"Interventions to improve the management of pain in emergency departments: systematic review and narrative synthesis","volume":"31","author":"Sampson","year":"2014","journal-title":"Emerg Med J"},{"key":"10.1016\/j.ajem.2023.04.020_bb0045","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1177\/1060028019863144","article-title":"Sufentanil sublingual tablet: a new option for acute pain management","volume":"53","author":"Reardon","year":"2019","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ajem.2023.04.020_bb0050","author":"Government of Canada HC"},{"key":"10.1016\/j.ajem.2023.04.020_bb0055","article-title":"Efficacy and safety of sufentanil sublingual tablet system in postoperative pain management: a systematic review and meta-analysis","author":"Thangaraju","year":"2021","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.ajem.2023.04.020_bb0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40122-020-00166-4","article-title":"Sufentanil sublingual for acute post-operative pain: a systematic literature review focused on pain intensity, adverse events, and patient satisfaction","volume":"9","author":"Giaccari","year":"2020","journal-title":"Pain Ther"},{"key":"10.1016\/j.ajem.2023.04.020_bb0065","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/0269216308100249","article-title":"Intranasal sufentanil for cancer-associated breakthrough pain","volume":"23","author":"Good","year":"2009","journal-title":"Palliat Med"},{"key":"10.1016\/j.ajem.2023.04.020_bb0070","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0885-3924(02)00406-2","article-title":"Pilot dose finding study of intranasal sufentanil for breakthrough and incident cancer-associated pain","volume":"23","author":"Jackson","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ajem.2023.04.020_bb0080","first-page":"114","article-title":"Intranasal sufentanil\/midazolam versus ketamine\/midazolam for analgesia\/sedation in the pediatric population prior to undergoing multiple dental extractions under general anesthesia: a prospective, double-blind, randomized comparison","volume":"51","author":"Roelofse","year":"2004","journal-title":"Anesth Prog"},{"key":"10.1016\/j.ajem.2023.04.020_bb0085","doi-asserted-by":"crossref","first-page":"41256","DOI":"10.18632\/oncotarget.17169","article-title":"Dexmedetomidine plus sufentanil for pediatric flexible bronchoscopy: a retrospective clinical trial","volume":"8","author":"Dang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajem.2023.04.020_bb0090","first-page":"4","article-title":"Comparison between the effects of alfentanil, fentanyl and sufentanil on hemodynamic indices during rapid sequence intubation in the emergency department","author":"Pouraghaei","year":"2014","journal-title":"Anesthesiol Pain Med"},{"key":"10.1016\/j.ajem.2023.04.020_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002849","article-title":"Intranasal sufentanil versus intravenous morphine for acute severe trauma pain: a double-blind randomized non-inferiority study","volume":"16","author":"Blancher","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajem.2023.04.020_bb0100","author":"Sandoz Canada Inc"},{"key":"10.1016\/j.ajem.2023.04.020_bb0105","first-page":"1165","article-title":"Sufentanil: pharmacolgy and current applications in clinical practice","volume":"10","author":"Sagir","year":"2022","journal-title":"J Pharmacol Clin Toxicol"},{"key":"10.1016\/j.ajem.2023.04.020_bb0110","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/0885-3924(92)90047-L","article-title":"The history and development of the fentanyl series","volume":"7","author":"Stanley","year":"1992","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ajem.2023.04.020_bb0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1213\/00000539-199001000-00003","article-title":"Differences in magnitude and duration of opioid-induced respiratory depression and analgesia with fentanyl and sufentanil","volume":"70","author":"Bailey","year":"1990","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ajem.2023.04.020_bb0120","first-page":"35","article-title":"Sufentanil in anesthesiology and intensive therapy","volume":"44","author":"Maciejewski","year":"2012","journal-title":"Anaesthesiol Intensive Ther"},{"key":"10.1016\/j.ajem.2023.04.020_bb0125","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s11739-018-02014-y","article-title":"Intranasal sufentanil given in the emergency department triage zone for severe acute traumatic pain: a randomized double-blind controlled trial","volume":"14","author":"Lemoel","year":"2019","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.ajem.2023.04.020_bb0130","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.annemergmed.2010.03.020","article-title":"Sufentanil is not superior to morphine for the treatment of acute traumatic pain in an emergency setting: a randomized, double-blind, out-of-hospital trial","volume":"56","author":"Bounes","year":"2010","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2023.04.020_bb0135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jemermed.2018.12.002","article-title":"Intranasal sufentanil versus intravenous morphine for acute pain in the emergency department: a randomized pilot trial","volume":"56","author":"Sin","year":"2019","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ajem.2023.04.020_bb0140","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ajem.2017.10.058","article-title":"Sufentanil sublingual tablet 30mcg for moderate-to-severe acute pain in the ED","volume":"36","author":"Miner","year":"2018","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2023.04.020_bb0145","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.ajem.2012.02.019","article-title":"Intranasal sufentanil for the treatment of acute pain in a winter resort clinic","volume":"30","author":"Steenblik","year":"2012","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2023.04.020_bb0150","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5055\/jom.2012.0121","article-title":"Intranasal sufentanil provides adequate analgesia for emergency department patients with extremity injuries","volume":"8","author":"Stephen","year":"2012","journal-title":"J Opioid Manag"},{"key":"10.1016\/j.ajem.2023.04.020_bb0155","article-title":"Intranasal sufentanil compared with a classic protocol for acute pain management in an emergency department: a prospective sequential study","author":"Kreps","year":"2021","journal-title":"Trauma"},{"key":"10.1016\/j.ajem.2023.04.020_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.ajem.2023.04.020_bb0165","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS peer review of electronic search strategies: 2015 guideline statement","volume":"75","author":"McGowan","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ajem.2023.04.020_bb0170","unstructured":"Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. Available at: www.covidence.org."},{"key":"10.1016\/j.ajem.2023.04.020_bb0175","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1197\/aemj.10.4.390","article-title":"Validation of a verbally administered numerical rating scale of acute pain for use in the emergency department","volume":"10","author":"Bijur","year":"2003","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ajem.2023.04.020_bb0180","first-page":"1","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ajem.2023.04.020_bb0185","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2147\/JPR.S291359","article-title":"Patient and healthcare professional satisfaction ratings and safety profile of sufentanil sublingual tablets for treatment of acute pain: a pooled demographic analysis","volume":"14","author":"Leiman","year":"2021","journal-title":"J Pain Res"},{"key":"10.1016\/j.ajem.2023.04.020_bb0190","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jopan.2019.08.009","article-title":"Pooled dosing and efficacy analysis of the sufentanil sublingual tablet 30 mcg across demographic subgroups for the management of moderate-to-severe acute pain","volume":"35","author":"Hutchins","year":"2020","journal-title":"J Perianesth Nurs"},{"key":"10.1016\/j.ajem.2023.04.020_bb0195","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2217\/pmt-2018-0090","article-title":"Pooled phase III safety analysis of sufentanil sublingual tablets for short-term treatment of moderate-to-severe acute pain","volume":"9","author":"Miner","year":"2019","journal-title":"Pain Manag"},{"key":"10.1016\/j.ajem.2023.04.020_bb0200","author":"Stephen"},{"key":"10.1016\/j.ajem.2023.04.020_bb0205","author":"Centre Hospitalier Universitaire de Nice"},{"key":"10.1016\/j.ajem.2023.04.020_bb0210","author":"Galinski"},{"key":"10.1016\/j.ajem.2023.04.020_bb0215","author":"Kreps"},{"key":"10.1016\/j.ajem.2023.04.020_bb0220","series-title":"A phase 3 open label study of the sufentanil sublingual 30mcg tablet for treatment of acute pain in the emergency department","first-page":"5","author":"Miner","year":"2016"},{"key":"10.1016\/j.ajem.2023.04.020_bb0225","first-page":"S32","article-title":"Predictors of adverse events in patients receiving opioids in an emergency setting: a prospective large observational cohort study [SAEM abstracts, plenary session]","volume":"18","author":"Ducasse","year":"2011","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ajem.2023.04.020_bb0230","article-title":"Comprehensive efficacy and integrated safety results from the late-phase clinical program of the sufentanil sublingual tablet 30 mcg [abstract]","volume":"42","author":"Minkowitz","year":"2017","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.ajem.2023.04.020_bb0235","first-page":"S284","article-title":"Gender differences in safety and efficacy of the sufentanil sublingual tablet 30 mcg for treatment of acute moderate to severe pain in the emergency department [SAEM annual meeting abstracts]","volume":"25","author":"Miner","year":"2018","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ajem.2023.04.020_bb0240","series-title":"Safety and efficacy of sufentanil sublingual tablet 30 MCG for management of acute traumatic pain [abstract from the 37th International Symposium on Intensive Care and Emergency Medicine, Brussels]","first-page":"21","author":"Miner","year":"2017"},{"key":"10.1016\/j.ajem.2023.04.020_bb0245","series-title":"Comprehensive efficacy and integrated safety results from the late-phase clinical program of the sufentanil sublingual tablet 30 mcg [abstract from the second European emergency medical services congress]","volume":"A16","author":"Leto","year":"2017"},{"key":"10.1016\/j.ajem.2023.04.020_bb0250","first-page":"116","article-title":"Intranasal sufentanil versus intravenous morphine sulfate in pain management of patients with extremity trauma","volume":"2","author":"Dolatabadi","year":"2015","journal-title":"Iran J Emerg Med"},{"key":"10.1016\/j.ajem.2023.04.020_bb0255","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/03007995.2017.1294559","article-title":"Sublingual, transdermal and intravenous patient-controlled analgesia for acute post-operative pain: systematic literature review and mixed treatment comparison","volume":"33","author":"Katz","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ajem.2023.04.020_bb0260","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/pan.12268","article-title":"Intranasal sufentanil\/ketamine analgesia in children","volume":"24","author":"Nielsen","year":"2014","journal-title":"Pediatr Anesth"},{"key":"10.1016\/j.ajem.2023.04.020_bb0265","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0009-9236(96)80012-9","article-title":"Comparison of intranasal midazolam and sufentanil premedication in pediatric outpatients","volume":"59","author":"Zedie","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ajem.2023.04.020_bb0270","first-page":"2","article-title":"Pain management in the emergency department: a review article on options and methods","author":"Abdolrazaghnejad","year":"2018","journal-title":"Adv J Emerg Med"},{"key":"10.1016\/j.ajem.2023.04.020_bb0275","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s11739-019-02069-5","article-title":"Intranasal sufentanil given in the emergency department triage zone for severe acute traumatic pain\u2014a randomized double-blind controlled trail: comment","volume":"14","author":"Corcostegui","year":"2019","journal-title":"Intern Emerg Med"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675723002085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675723002085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:05:36Z","timestamp":1760025936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675723002085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":54,"alternative-id":["S0735675723002085"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2023.04.020","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of sufentanil for the management of adults with acute pain in the emergency department and pre-hospital setting","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2023.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}